Latest publications Ueland group

Ormerod MBEG, Sheikh MA, Ueland T, Hjell G, Rødevand L, Sæther LS, Lunding SH, Johansen IT, Andreou D, Ueland T, Lagerberg TV, Melle I, Djurovic S, Andreassen OA, Steen NE (2025)
Minor immunomodulatory effects of psychotropics suggested in severe mental disorders: associations of antipsychotics with beta defensin 2, antidepressants with C-reactive protein, and mood stabilizers with soluble interleukin 2 receptor
Eur Psychiatry, 1-28 (in press)
DOI 10.1192/j.eurpsy.2025.10104, PubMed 40936381

Aamodt AH, Ueland T, Boldingh M, Bezgal BE, Argren MB, Dunne CA, Otterdal K, Gregersen I, Bjerkeli V, Michelsen AE, Husøy A, Morsund ÅH, Devik K, Poole AC, Gjendemsjø KB, Schlüter K, Mathisen SM, Aalstad-Johansen M, Skattør TH, Sønnervik J, Boye TB, Popperud TH, Høgestøl EA, Harbo HF, Lund-Johansen F et al. (2025)
Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination
BMJ Neurol Open, 7 (2), e001013
DOI 10.1136/bmjno-2024-001013, PubMed 40881041

Nilsen DWT, Leon De La Fuente R, Gallo P, Naesgaard P, Dib Ashur S, Michelsen AE, Aukrust P, Staines H, Ueland T (2025)
Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
Int J Cardiol, 441, 133812
DOI 10.1016/j.ijcard.2025.133812, PubMed 40850571